Beta Bionics Inc., a trailblazer in insulin delivery technology, made waves in the stock market Thursday after pricing an ...

MaxCyte Inc., a leading cell therapy and gene editing company, announced Thursday that it has acquired SeQure Dx, a specialized gene editing firm, in a deal worth up to $7 million. The move is aimed ...